High HbA1c Level

1 clinical trials · Condition

Record	Firm	Date
Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea (NCT01392677)	AstraZeneca	2011-10-01

Every clearance here is in the API, with alerts when new ones post.